News
gla_wpadmin  

US Pharmaceuticals Agency grants emergency approval for Covid-19 tablet from Pfizer

Wednesday, 12/22/2021 7:58 PM from

dpa-AFX

| Views: 89

Various drugs in tablet and capsule form. (Symbol picture) © pixabay.com/CC0

https://pixabay.com

WASHINGTON (dpa-AFX) – The US drug agency FDA received emergency approval for a corona drug from the US manufacturer Pfizer on Wednesday pronounced. Corona patients aged twelve and over who have tested positive with mild to moderate symptoms and a high risk of worsening the disease are to be treated with Paxlovid. According to the FDA, it is the first Covid drug in the US that can be taken in pill form.

The drug is said to be available on prescription in the US but free of charge. The US government said it had bought ten million cans for $ 5.3 billion. Deliveries could start this year. In Europe, the EMA announced in mid-November that it had started an investigation into the Covid-19 drug.

According to the company from the beginning of November, the corona pill is very successful in preventing serious illnesses in high-risk patients. An interim analysis of test results found the drug reduced the risk of hospital admissions and death in Covid-19 patients by 89 percent, according to Pfizer. Possible side effects include impaired taste, diarrhea, high blood pressure, and muscle pain.

advertising

Further up?

Vontobel

The base prospectus as well as the final terms and the key information sheets are available here: VX4TP8,VX3PE4,. Also note the further notes to this advertisement. The issuer is entitled to terminate securities with an open-end term.

advertising

Subscribe to more news about the Niocorp Developments share free of charge

Notice:
ARIVA.DE publishes analyzes, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that has been recognized by third parties in the “News” area of ​​this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” mark below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.

Other users were also interested in this article:

Reference-www.ariva.de

Leave A Comment